A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: | Recruiting |
---|---|
Conditions: | Migraine Headaches |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 6 - 17 |
Updated: | 2/21/2019 |
Start Date: | March 14, 2018 |
End Date: | November 30, 2022 |
Contact: | There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or |
Email: | Clinicaltrials.gov@lilly.com |
Phone: | 1-317-615-4559 |
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD Study
The main purpose of this study is to determine the safety and efficacy of the study drug
galcanezumab in participants 6 to 17 years of age with episodic migraine.
galcanezumab in participants 6 to 17 years of age with episodic migraine.
Inclusion Criteria:
- Have a diagnosis of migraine as defined by the International Headache Society
International Classification of Headache Disorders (IHS ICHD-3) beta guidelines (1.1
or 1.2) (ICHD-3 2013), with a history of migraine headaches of at least 6 months prior
to screening.
Exclusion Criteria:
- Participants who are taking, or are expected to take, therapeutic antibodies during
the course of the study (adalimumab, infliximab, trastuzumab, bevacizumab, etc.).
Prior use of therapeutic antibodies, other than antibodies to calcitonin gene-related
peptide (CGRP) or its receptor, is allowed if that use was more than 12 months prior
to baseline.
- Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic
proteins, or to galcanezumab or its excipients.
- Current use or prior exposure to galcanezumab, another CGRP antibody, or CGRP receptor
antibody, including those who have previously completed or withdrawn from this study
or any other study investigating a CGRP antibody.
- History of persistent daily headache, cluster headache or migraine subtypes including
hemiplegic (sporadic or familial) migraine and migraine with brainstem aura
(previously basilar-type migraine) as defined by IHS ICHD-3 beta.
- History of any type of headache except for migraine, tension type headache, or
medication overuse headache, as defined by IHS ICHD-3 beta, in the 3 months prior to
randomization. For example, a history of post-traumatic headache in this 3-month
period would not be allowed.
- History of traumatic head injury, associated with significant change in the quality or
frequency of their headaches, including new onset of migraine following traumatic head
injury.
- Participants with a known history of intracranial tumors or developmental
malformations including Chiari malformations.
We found this trial at
16
sites
San Diego, California 92108
Principal Investigator: Dane M. Shipp
Phone: 619-521-2830
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Principal Investigator: Marielle Kabbouche-Samaha
Phone: 513-636-4222
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
5323 Harry Hines Blvd
Dallas, Texas 75235
Dallas, Texas 75235
(214) 648-3111
Principal Investigator: Eric Remster
Phone: 214-867-6906
Univ of Texas, Southwestern Med Ctr of Dallas The story of UT Southwestern Medical Center...
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
215-590-1000
Principal Investigator: Christina L Szperka
Phone: 215-590-1419
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials
1 Tampa General Cir
Tampa, Florida 33606
Tampa, Florida 33606
(813) 844-7000
Principal Investigator: Kavita Kalidas
Phone: 321-331-6768
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
Click here to add this to my saved trials
Amherst, New York 14226
Principal Investigator: Jennifer Williams McVige
Phone: 7162502000
Click here to add this to my saved trials
5673 Ptree Dun Rd NE # 440
Atlanta, Georgia 30342
Atlanta, Georgia 30342
Principal Investigator: Frank Berenson
Phone: 678-705-7341
Click here to add this to my saved trials
Bellevue, Washington 98007
Principal Investigator: Arifulla Khan
Phone: 425-453-0404
Click here to add this to my saved trials
Click here to add this to my saved trials
1555 North Barrington Road
Hoffman Estates, Illinois 60169
Hoffman Estates, Illinois 60169
Principal Investigator: Hossam AbdelSalam
Phone: 847-593-8553
Click here to add this to my saved trials
Jacksonville, Florida 32216
Principal Investigator: Nandita M Jones
Phone: 904-281-5757
Click here to add this to my saved trials
Minneapolis, Minnesota 55402
Principal Investigator: Gary D. Berman
Phone: 612-333-2200
Click here to add this to my saved trials
Click here to add this to my saved trials
Orlando, Florida 32801
Principal Investigator: Linda S Harper
Phone: 407-425-5100
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15243
Principal Investigator: Nathan L Bennett
Phone: 412-650-6155
Click here to add this to my saved trials
West Palm Beach, Florida 33407
Principal Investigator: Paul K Winner
Phone: 561-845-0500
Click here to add this to my saved trials